Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-12

Clinical Trial Update: Botulinum Toxin A in the Treatment of Hemifacial Spasm [NA]

View source ↗

Summary

This entry reports on a Tongji University-sponsored clinical trial evaluating botulinum toxin type A for hemifacial spasm; the trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Tongji University | Conditions: Hemifacial Spasm | NA | Status: UNKNOWN